Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial

Vicky Makker, Drew Rasco, Nicholas J. Vogelzang, Marcia S. Brose, Allen L. Cohn, James Mier, Christopher Di Simone, David M. Hyman, Daniel E. Stepan, Corina E. Dutcus, Emmett V. Schmidt, Matthew Guo, Pallavi Sachdev, Robert Shumaker, Carol Aghajanian, Matthew Taylor

    Research output: Contribution to journalArticlepeer-review

    138 Scopus citations

    Fingerprint Dive into the research topics of 'Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial'. Together they form a unique fingerprint.

    Medicine & Life Sciences